Mechanism(s) Underlying Cardiovascular Effects of ARB/NEP Inhibition - Aim 2

Clinical trial NCT03005184 · WITHDRAWN

Trial details

NCT number: NCT03005184
Sponsor: Vanderbilt University Medical Center
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Heart Failure NYHA Class I Heart Failure NYHA Class II Heart Failure NYHA Class III

Start date: 2017-09-01
Primary completion: 2020-01-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.